References
- Reploeg MD, Goebel JA. Migraine associated dizziness: patient characteristics and management options. Otology and Neurology 2002; 23: 364–71.
- Lempert T, Neuhauser H. Migrainous vertigo. Neurologic Clinics 2005; 23: 715–30.
- Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 1984: 107: 1123–42.
- Benson AG, Chark DW, Djalilian HR, et al. Migraine-associated vertigo. eMedicine (Otolaryngology and Facial Plastic Surgery). Nov 2008.
- Sacks OW. Migraine: the evolution of a common disorder. London: Faber, 1970.
- International Headache Society Classification Subcommittee. International classification of headache disorders, 2nd ed.. Cephalalgia 2004: 24 (Suppl 1): 1–160.
- Neuhasuer H, Leopold M, Von Vrevern M, et al. The interrelations of migraine, vertigo and migrainous vertigo. Neurology 2001; 56; 436–41.
- Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 1991; 44: 1147–57.
- Lee H, Sininger L, Jen-Yoon-Hee Cha JC, et al. Association of progesterone receptor with migraine-associated vertigo. Neurogenetics 2007; 8(3): 195–200.
- Celebisoy N, Cokcay F, Sirin H, Bicak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia 2008; 28: 72–7. London ISSN 03333–1024.
- Becker WJ. The use of oral contraceptives in patients with migraine. Neurology 1999; 53(4, Suppl 1): 519–25.
- Viirre ES, Baloh RW. Migraine as a cause of sudden hearing loss. Headache 1996; 36(1): 24–8.
- Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992; 32(6): 300–4.
- Bes A, Dupai P, Guell A, et al. Pharmacological exploration of dopamine hypersensitivity in migraine patients. Int J Clin Pharmacol Res 1986; 6: 189–92.
- Lempert T, Neuhauser H. Epidemiology and clinical aspects of migraine-associated dizziness (abstract 173). In: Abstracts: Barany Society XXIII International Congress. J Vest Res 2004; 14: 180.